wada bpc 157 BPC-157: Experimental Peptide Creates Risk for Athletes The Prohibited List | World

For most people, yes, when it is medically appropriate and supervised

doi: 10.1172/JCI118371

The company is headquartered in Vancouver, British Columbia, as indicated by the dateline of the July 14, 2026 announcement

No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance